Reata Pharmaceuticals, Inc. (RETA)
(Delayed Data from NSDQ)
$80.41 USD
+2.31 (2.96%)
Updated May 3, 2019 04:00 PM ET
After-Market: $80.37 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For RETA
-
Why Is Reata Pharmaceuticals, Inc. (RETA) Up 6.9% Since Last Earnings Report?
-
Reata (RETA) Q1 Earnings Miss, Stock Dips on Pipeline Updates
-
Reata Pharmaceuticals, Inc. (RETA) Down 1.3% Since Last Earnings Report: Can It Rebound?
-
Reata (RETA) Q3 Earnings Beat, Stock Up on Pipeline Updates
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Lags Revenue Estimates
-
Reata Pharmaceuticals, Inc. (RETA) Up 4.7% Since Last Earnings Report: Can It Continue?
-
Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q2 Loss, Lags Revenue Estimates
-
Why Is Reata Pharmaceuticals, Inc. (RETA) Up 53.1% Since Last Earnings Report?
-
Reata (RETA) Q1 Earnings Top, Omaveloxolone MAA Likely in Q4
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q1 Loss, Misses Revenue Estimates
-
Reata Pharmaceuticals, Inc. (RETA) Up 3.9% Since Last Earnings Report: Can It Continue?
-
Reata's (RETA) Q4 Earnings Miss Mark, Revenues Decline Y/Y
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q4 Loss, Lags Revenue Estimates
-
Earnings Preview: Reata Pharmaceuticals, Inc. (RETA) Q4 Earnings Expected to Decline
-
Reata (RETA) Stock Up Following Q3 Earnings & Sales Beat
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Reata Pharmaceuticals, Inc. (RETA) Q3 Earnings Expected to Decline
-
Why Is Reata Pharmaceuticals, Inc. (RETA) Up 12.2% Since Last Earnings Report?
-
Reata (RETA) Stock Down Despite Q2 Earnings & Sales Beat
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q2 Loss, Tops Revenue Estimates
-
Analysts Estimate Reata Pharmaceuticals, Inc. (RETA) to Report a Decline in Earnings: What to Look Out for
-
Reata's (RETA) Q1 Earnings Beat Estimates, Revenues Miss
-
Reata Pharmaceuticals, Inc. (RETA) Reports Q1 Loss, Lags Revenue Estimates
-
Earnings Preview: Reata Pharmaceuticals, Inc. (RETA) Q1 Earnings Expected to Decline